• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 12, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Human artificial chromosomes bypass centromere roadblocks

Bioengineer by Bioengineer
July 25, 2019
in Chemistry
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Human artificial chromosomes (HACs) could be useful tools for both understanding how mammalian chromosomes function and creating synthetic biological systems, but for the last 20 years, they have been limited by an inefficient artificial centromere. In the journal Cell on July 25th, researchers announce that they have made progress on this key component.

“The centromere used to be called the black box of the chromosome,” says Ben Black, professor of biochemistry and biophysics at the University of Pennsylvania. “If you’re studying any kind of biological process, you want to be able to build it, and that’s where we’ve made progress here.”

In mammals, centromeres–the central point of the X-shaped chromosome–ensure that a chromosome is inherited when a cell divides, acting as an anchor for the spindle fibers that pull the duplicated chromosome in half. The genetic sequence of a natural human centromere is thousands of repetitions of a 171-base-pair sequence. Centromeric DNA must also be modified epigenetically in the cell to function properly. These epigenetic marks (protein and chemical tags along the DNA) are thought to be established at centromeres by the human CENP proteins.

First-generation HACs have relied on both the repetitive centromere sequence and CENP-B. But the repetitive sequence make centromeres tricky to clone for study in the lab. Therefore, “all of the synthetic chromosomes that have been recently reported use approaches that intentionally remove repetitive elements,” Black says, making it so far impossible to transition the techniques that work in yeast artificial chromosomes to HACs.

Black’s team has now created two new HACs: neither use CENP-B, and one is not repetitive. “We wanted to see if we can break the rules by bestowing the DNA we put into the cell with epigenetic markers from the get go,” says Black. Their improvements remove the requirement for CENP-B, make the HACs more reliably inherited in cell culture, and provided the opportunity for the researchers to study them with genomic approaches, which had previously been impossible.

CENP-B, though not essential for natural chromosomes, has been assumed to be required for artificial centromere formation until now. A closely related protein, CENP-A, is actually the essential epigenetic marker for centromeres, and Black and his team have been able to direct the assembly of CENP-A onto the incoming HAC DNA.

The next-generation HACs made by Black and his team will allow for more thorough study of the essential components of functional chromosomes. Because a version of their HAC does not have the long repeating section, Black’s team was able to use genomic approaches to analyze the sequence where centromeres formed. More reliable HACs will also open the door to complex synthetic biological systems that require longer sequences than can fit in viruses, the current common mode of delivering synthetic genetic systems.

###

This work was supported by the National Institutes of Health, the UPenn Cell and Molecular Biology Training Grant, the European Research Council, and the Wellcome Trust Senior Researcher Fellowship. The authors declare no conflict of interest.

Cell, Logsdon et al.: “Human Artificial Chromosomes that Bypass Centromeric DNA” https://www.cell.com/cell/fulltext/S0092-8674(19)30634-8

Cell (@CellCellPress), the flagship journal of Cell Press, is a bimonthly journal that publishes findings of unusual significance in any area of experimental biology, including but not limited to cell biology, molecular biology, neuroscience, immunology, virology and microbiology, cancer, human genetics, systems biology, signaling, and disease mechanisms and therapeutics. Visit: http://www.cell.com/cell. To receive Cell Press media alerts, contact [email protected].

Media Contact
Theresa Machemer
[email protected]
http://dx.doi.org/10.1016/j.cell.2019.06.006

Tags: BiochemistryBiologyBiomedical/Environmental/Chemical EngineeringBiotechnologyGenesGeneticsMolecular Biology
Share12Tweet8Share2ShareShareShare2

Related Posts

Random-Event Clocks Offer New Window into the Universe’s Quantum Nature

Random-Event Clocks Offer New Window into the Universe’s Quantum Nature

September 11, 2025
Portable Light-Based Brain Monitor Demonstrates Potential for Advancing Dementia Diagnosis

Portable Light-Based Brain Monitor Demonstrates Potential for Advancing Dementia Diagnosis

September 11, 2025

Scientists reinvigorate pinhole camera technology for advanced next-generation infrared imaging

September 11, 2025

BeAble Capital Invests in UJI Spin-Off Molecular Sustainable Solutions to Advance Disinfection and Sterilization Technologies

September 11, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    64 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Gal-9 on Leukemia Stem Cells Predicts Prognosis

Auranofin’s Anti-Leishmanial Effects: Lab and Animal Studies

Nanomedicine: A New Frontier in Targeting Metastasis

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.